Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov 30;130(22):2386-2391.
doi: 10.1182/blood-2017-05-782029.

Advances in the diagnosis and treatment of Von Willebrand disease

Ruchika Sharma  1   2 , Veronica H Flood  1   2   3
Affiliations
Review

Advances in the diagnosis and treatment of Von Willebrand disease

Ruchika Sharma et al. Blood. .

Abstract

Von Willebrand disease (VWD) is the most common inherited bleeding disorder, yet diagnosis and management remain challenging. Development and use of bleeding assessment tools allows for improved stratification of which patients may require further assessment and which patients are most likely to require treatment of their VWD. New options for laboratory assessment of von Willebrand factor (VWF) activity include a new platelet-binding assay, the VWF:GPIbM, which is subject to less variability than the ristocetin cofactor activity assay, and collagen-binding assays that provide insight into a different function of VWF. Genetic testing may be helpful in some cases where a type 2 VWD variant is suspected but is usually not helpful in type 1 VWD. Finally, treatment options for VWD are reviewed, including the use of recombinant VWF. Despite these advances, still more work is required to improve diagnosis, treatment, and quality of life for affected patients.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: R.S. declares no competing financial interest. V.H.F. has consulted for CSL Behring and Shire. Off-label drug use: None disclosed.

Figures

Figure 1.
Figure 1.
Genetic variants in VWF in type 1 VWD. Frequency of genetic variants in VWF for 5 large population studies of type 1 VWD including the United Kingdom, European Union, Canada, Germany, and United States. Overall 65% had a variant in VWF found, but 35% did not.
See this image and copyright information in PMC

References

    1. Bowman M, Hopman WM, Rapson D, Lillicrap D, James P. The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost. 2010;8(1):213-216. - PubMed
    1. Robertson J, Lillicrap D, James PD. Von Willebrand disease. Pediatr Clin North Am. 2008;55(2):377-392. - PubMed
    1. Nichols WL, Hultin MB, James AH, et al. . von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14(2):171-232. - PubMed
    1. Castaman G, Federici AB, Tosetto A, et al. . Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients. J Thromb Haemost. 2012;10(4):632-638. - PubMed
    1. Rodeghiero F, Tosetto A, Abshire T, et al. ; ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063-2065. - PubMed

Publication types